The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt
Abstract Background Programmed death ligand-1 (PD-L1), anaplastic lymphoma kinase (ALK), and c-ros oncogene1 (ROS1) expression may influence the prognosis of non-small cell lung carcinoma (NSCLC). We aimed to investigate the prognostic and predictive significance of PD-1/PD-L1 along with c-ros ROS1...
Main Authors: | Abeer A. Bahnassy, Hoda Ismail, Marwa Mohanad, Ahmed El-Bastawisy, Hend F. Yousef |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-05-01
|
Series: | Journal of the Egyptian National Cancer Institute |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43046-022-00121-8 |
Similar Items
-
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
by: Douglas D. Fang, et al.
Published: (2022-07-01) -
Percentages of PD-1+CD4+T cells and PD-L1+DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia
by: Yingying Wang, et al.
Published: (2018-04-01) -
PD-L1 and PD-1 in immune regulation and their implications in blood cancers
by: Parisa Shiri Aghbash, et al.
Published: (2024-10-01) -
Programmed death-1 (PD-1) ligand 1 and PD-1 ligand 2 expressions and their clinical relevance in colorectal cancer
by: Jee Hyun Ahn, et al.
Published: (2017-12-01) -
GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
by: Young Wha Koh, et al.
Published: (2017-03-01)